Veterinary Oxygen Therapy Market Size & Growth Forecast 2027–2036, By Segments (Product, Animal Type, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Oxygen Therapy Market size stood at USD 1.5 billion in 2026 and is predicted to grow at a 7.25% CAGR from 2027 to 2036, exceeding USD 3.02 billion by 2036. The industry revenue for 2027 is assessed at USD 1.59 billion.
Get more details on this report
Request Free Sample ReportVeterinary Oxygen Therapy Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 40.81% share, supported by advanced veterinary infrastructure, widespread use of oxygen-based treatments, and strong adoption in emergency and post-operative animal care.
- Asia Pacific is growing at 8.59% CAGR due to modernization of veterinary services and increasing adoption of respiratory support systems across companion animal care facilities.
Segment Momentum
- Veterinary oxygen concentrators lead with 80.47% share due to reliable on-site oxygen delivery, reduced cylinder dependence, and operational efficiency in clinics for emergency care, surgery, and recovery support.
- Small animals lead and grow fastest due to high treatment volumes in companion animals, where oxygen therapy is frequently required for surgery, respiratory distress, and emergency stabilization care.
Market Expansion Drivers
- Rising respiratory and critical illness cases in animals driving oxygen therapy demand.
- Expansion of veterinary hospitals and specialty clinics strengthening critical care infrastructure.
- Development of portable oxygen systems enabling mobile and emergency veterinary care delivery.
Leading Market Participants
- Leading players in the veterinary oxygen therapy market include Koninklijke Philips N.V. (Netherlands), CAIRE Inc. (United States), Drive DeVilbiss International (United States), Longfian Scitech Co., Ltd. (China), Vetland Medical Sales & Services LLC (United States), RWD Life Science Co., Ltd. (China), IMEX Medical Limited (United Kingdom), Airnetics LLC (United States), AEOLUS International Pet Products, LLC (United States), Shinova Systems (India).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.5 billion
- 2027 Estimated Market Size: USD 1.59 billion.
- Projected Market Size: USD 3.02 billion by 2036
- Growth Forecast: 7.25% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Veterinary Oxygen Concentrator (Product) | Small Animals (Animal Type) | ICU (Application) | Veterinary Hospitals (End-use)
- Emerging Opportunity Segment: Veterinary Oxygen Concentrator (Product) | Small Animals (Animal Type) | Homecare Setting/postoperative Care (Application) | Veterinary Clinics (End-use)
Market Growth Drivers and Industry Trends
Rising respiratory and critical illness cases in animals driving oxygen therapy demand
The increasing occurrence of respiratory disorders, trauma, surgical complications, and other critical conditions requiring respiratory support is strengthening the veterinary oxygen therapy market demand. Oxygen supplementation is an important component of emergency and intensive veterinary care when animals experience impaired breathing, reduced oxygen saturation, or compromised pulmonary function. Veterinary facilities use oxygen cages, masks, nasal delivery systems, and other equipment to provide controlled oxygen concentrations according to the condition and size of the animal. Greater awareness of advanced clinical management for companion animals and the increasing use of intensive treatment protocols are also encouraging veterinary professionals to incorporate oxygen support into emergency and critical care procedures.
Expansion of veterinary hospitals and specialty clinics strengthening critical care infrastructure
The growth of veterinary hospitals and specialized clinical facilities is expanding access to advanced diagnostic and treatment capabilities, which will drive the veterinary oxygen therapy market growth. Specialty hospitals increasingly provide services such as surgery, emergency medicine, oncology, cardiology, and intensive care that require reliable respiratory support equipment for patients undergoing complex procedures or experiencing acute medical conditions. As veterinary facilities expand their treatment capabilities, investments in monitoring devices, oxygen delivery systems, anesthesia equipment, and intensive care infrastructure become increasingly important. Dedicated critical care environments also require equipment capable of delivering controlled oxygen therapy across different patient sizes and clinical circumstances, from routine postoperative support to emergency stabilization.
Development of portable oxygen systems enabling mobile and emergency veterinary care delivery
Advances in compact and portable oxygen delivery equipment are expanding the settings in which respiratory support can be provided, creating new opportunities for the veterinary oxygen therapy market. Portable systems can support oxygen administration during animal transportation, field treatment, home-based veterinary services, and emergency response situations where access to fixed clinical infrastructure may be limited. Lightweight designs, rechargeable power options, and simplified oxygen delivery mechanisms can make these systems easier for veterinary professionals to deploy outside conventional treatment rooms. Their mobility is particularly valuable when animals require immediate stabilization before reaching a hospital or when ongoing respiratory support must be maintained during transportation between veterinary facilities.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising respiratory and critical illness cases in animals driving oxygen therapy demand | 2.00% | Moderate | North America | High | Near Term |
| Expansion of veterinary hospitals and specialty clinics strengthening critical care infrastructure | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Development of portable oxygen systems enabling mobile and emergency veterinary care delivery | 1.60% | Low | Asia Pacific, North America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The veterinary oxygen therapy market was led by North America, which captured a 40.81% share in 2026, supported by advanced veterinary healthcare infrastructure, high pet ownership, and increasing expenditure on companion-animal medical care. Veterinary hospitals and specialty clinics increasingly use oxygen therapy for respiratory disorders, surgical recovery, trauma management, and critical-care cases requiring controlled oxygen supplementation. Greater availability of specialized veterinary services and improved awareness of animal health are supporting demand for dedicated oxygen delivery equipment and monitoring capabilities. The region's growing emphasis on comprehensive pet wellness and emergency care is further strengthening adoption across veterinary practices that are investing in more sophisticated clinical treatment environments.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is witnessing the fastest growth as veterinary care becomes more specialized and awareness of companion-animal health continues to increase. Rising urban pet ownership, expanding veterinary clinic networks, and improving access to advanced diagnostic and therapeutic services are broadening the addressable market for oxygen therapy. Veterinary professionals are also adopting more modern clinical practices for managing respiratory and critical-care conditions, particularly in urban centers with expanding specialty facilities. Improvements in veterinary infrastructure and increasing willingness among pet owners to pursue advanced treatment are creating favorable conditions for wider use of oxygen therapy equipment across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Equipment StandardizationGermany prioritizes veterinary oxygen therapy equipment that integrates smoothly into modern clinical workflows while meeting demanding quality expectations. Healthcare providers focus on dependable respiratory support systems for surgical procedures and intensive animal care.
France 🇫🇷
Integrated Respiratory SupportFrance incorporates veterinary oxygen therapy into comprehensive treatment protocols for companion animals requiring respiratory stabilization and recovery support. Clinics favor equipment offering dependable performance and compatibility with broader critical care infrastructure.
Italy 🇮🇹
Practice Modernization FocusItaly is modernizing veterinary practices through investment in oxygen therapy equipment that supports emergency treatment and surgical recovery. Veterinary professionals value practical systems that improve treatment consistency while remaining adaptable to varied clinic sizes.
Japan 🇯🇵
Companion Care EnhancementJapan continues expanding veterinary oxygen therapy adoption as clinics strengthen services for aging companion animals with respiratory conditions. Purchasing decisions emphasize compact equipment, operational reliability, and efficient integration into limited clinical spaces.
South Korea 🇰🇷
Specialty Clinic DevelopmentSouth Korea is expanding veterinary oxygen therapy capabilities as specialty animal hospitals broaden emergency and postoperative treatment services. Demand centers on user-friendly systems that enhance patient monitoring and respiratory care efficiency.
United States 🇺🇸
Advanced Critical CareThe U.S. veterinary oxygen therapy market is supported by growing investment in advanced companion animal treatment and emergency care capabilities. Veterinary hospitals increasingly adopt versatile oxygen delivery systems that improve respiratory support across diverse clinical settings.
Segment Leadership and Growth Trends
Veterinary Oxygen Therapy Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Veterinary Oxygen Concentrator (Largest & Fastest-Growing Segment)
The veterinary oxygen concentrator segment dominated the veterinary oxygen therapy market, holding the largest share in 2026 while also emerging as the fastest-growing product segment. Its strong position is supported by the growing need for reliable oxygen delivery during respiratory distress, anesthesia, recovery, and critical care in veterinary settings. Concentrators provide a practical source of supplemental oxygen by extracting oxygen from ambient air, reducing dependence on continuously replaced oxygen cylinders and supporting sustained treatment. Their operational convenience, portability across clinical environments, and suitability for both routine and emergency applications strengthen adoption among veterinary care providers. Continued emphasis on timely respiratory intervention and improved access to veterinary critical-care equipment is further reinforcing demand for oxygen concentrators.
Animal Type Segment Analysis: Small Animals (Largest & Fastest-Growing Segment)
Within the animal type category, small animals held the largest share in 2026 and are also positioned as the fastest-growing segment. The segment benefits from the widespread use of veterinary services for companion animals, where respiratory disorders, surgical procedures, trauma care, and post-treatment monitoring can require supplemental oxygen. Increasing attention to companion-animal health and greater willingness to pursue advanced veterinary treatment are encouraging broader use of oxygen therapy. The growing availability of specialized equipment designed for smaller patients, combined with demand for accessible emergency and critical-care services, is supporting continued expansion of oxygen therapy applications for small animals.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Veterinary Oxygen Concentrator, Accessories | Veterinary Oxygen Concentrator | Veterinary Oxygen Concentrator |
| Animal Type | Small Animals, Large Animals, Others | Small Animals | Small Animals |
| Application | ICU, Homecare Setting/postoperative Care, Others | ICU | Homecare Setting/postoperative Care |
| End-use | Veterinary Hospitals, Veterinary Clinics, Others | Veterinary Hospitals | Veterinary Clinics |
Competitive Landscape and Market Positioning
Key companies in the veterinary oxygen therapy market:
1. Koninklijke Philips N.V. (Netherlands)
2. CAIRE Inc. (United States)
3. Drive DeVilbiss International (United States)
4. Longfian Scitech Co. Ltd. (China)
5. Vetland Medical Sales & Services LLC (United States)
6. RWD Life Science Co. Ltd. (China)
7. IMEX Medical Limited (United Kingdom)
8. Airnetics LLC (United States)
9. AEOLUS International Pet Products LLC (United States)
10. Shinova Systems (India)
The veterinary oxygen therapy market is witnessing growing focus on critical care support solutions for animals. Equipment innovation is improving oxygen delivery precision and treatment safety. Rising veterinary healthcare standards are supporting broader adoption across clinical settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Koninklijke Philips N.V. (Netherlands) | |||||||
| CAIRE Inc. (United States) | |||||||
| Drive DeVilbiss International (United States) | |||||||
| Longfian Scitech Co. Ltd. (China) | |||||||
| Vetland Medical Sales & Services LLC (United States) | |||||||
| RWD Life Science Co. Ltd. (China) | |||||||
| IMEX Medical Limited (United Kingdom) | |||||||
| Airnetics LLC (United States) | |||||||
| AEOLUS International Pet Products LLC (United States) | |||||||
| Shinova Systems (India). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| BMV Animal Technology | Mar-25 | BMV Animal Technology introduced the BAM-5 Pro Turbo Ventilator and BAM-2 Oxygen Concentrator in March 2025, expanding its veterinary respiratory care portfolio. These devices enhance critical care capabilities in animal hospitals by improving ventilation efficiency and oxygen delivery, strengthening the company’s position in veterinary medical technology solutions. |
| Bionet America | Feb-25 | Bionet America launched the Super Air Smart ICU in February 2025, a next-generation veterinary critical care unit integrating advanced oxygenation, CO₂ management without soda-lime, ionization-based air purification, and climate control. The system aims to reduce operational workload and improve patient safety, positioning the company in high-end veterinary intensive care solutions. |
| Infinium Medical | Jan-25 | Infinium Medical entered an exclusive distribution partnership in January 2025 for Vapotherm VET 2.0, a high-flow oxygen therapy system for veterinary applications. The system enhances respiratory care through improved mobility, user-friendly design, and advanced medication delivery capabilities, strengthening Infinium’s veterinary portfolio and expanding access to advanced oxygen therapy technologies in clinical settings. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Oxygen Therapy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Oxygen Delivery Method | Continuous-Flow Delivery, Pulse-Dose Delivery, Oxygen Enclosure & Chamber Delivery |
| Veterinary Practice Size | Small Practices, Medium-Sized Practices, Large & Multi-Location Practices |
| Purchasing Model | Direct Equipment Purchase, Equipment Leasing & Rental, Managed Equipment & Supply Contracts |
Veterinary Oxygen Therapy Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Care Facility Adoption Analysis |
|
| Animal Health Treatment Opportunity Assessment |
|
| Oxygen Therapy Workflow Optimization Study |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the veterinary oxygen therapy market generate?
How much is the veterinary oxygen therapy industry expected to grow by 2036?
How are rising respiratory and critical illness cases driving demand in the veterinary oxygen therapy market?
How is the expansion of veterinary hospitals influencing oxygen therapy adoption?
Why does veterinary oxygen concentrator dominate the market?
Which animal segment is driving growth in veterinary oxygen therapy?
Why does North America lead the veterinary oxygen therapy market?
How is Asia Pacific driving growth in this market?
What are the prominent companies operating in the veterinary oxygen therapy landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization